Mark Manfredi
Founder bei IKENA ONCOLOGY, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Mark Manfredi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IKENA ONCOLOGY, INC. | Director/Board Member | 01.12.2017 | - |
| Chief Executive Officer | 01.12.2017 | - | |
| Founder | 01.02.2016 | - | |
| President | 01.12.2017 | - | |
| Chief Tech/Sci/R&D Officer | 01.03.2016 | 01.12.2017 | |
Amplify Medicines, Inc.
 Amplify Medicines, Inc. Pharmaceuticals: GenericHealth Technology Part of Ikena Oncology, Inc., Amplify Medicines, Inc. develops pharmaceutical drugs. The private company is based in Boston, MA. The company was founded by Peter Smith. | President | - | - |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | - | - |
Karriereverlauf von Mark Manfredi
Ehemalige bekannte Positionen von Mark Manfredi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Raze Therapeutics, Inc.
 Raze Therapeutics, Inc. BiotechnologyHealth Technology Raze Therapeutics, Inc. engages in the discovery and development of oncology therapeutics. It offers a pipeline of one-carbon (1C) metabolism therapeutics across solid and hematologic cancers, including genetically-defined cancers. The company was founded by Vamsi Mootha, Joshua Rabinowitz, David Sabatini, and Adam Friedman on August 8, 2014 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01.04.2015 | 01.04.2016 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - | - |
Ausbildung von Mark Manfredi
| University of Rhode Island | Undergraduate Degree |
| Boston College | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Japan | 2 |
Operativ
| President | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| IKENA ONCOLOGY, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Raze Therapeutics, Inc.
Raze Therapeutics, Inc. BiotechnologyHealth Technology Raze Therapeutics, Inc. engages in the discovery and development of oncology therapeutics. It offers a pipeline of one-carbon (1C) metabolism therapeutics across solid and hematologic cancers, including genetically-defined cancers. The company was founded by Vamsi Mootha, Joshua Rabinowitz, David Sabatini, and Adam Friedman on August 8, 2014 and is headquartered in Cambridge, MA. | Health Technology |
Amplify Medicines, Inc.
Amplify Medicines, Inc. Pharmaceuticals: GenericHealth Technology Part of Ikena Oncology, Inc., Amplify Medicines, Inc. develops pharmaceutical drugs. The private company is based in Boston, MA. The company was founded by Peter Smith. | Health Technology |
- Börse
- Insiders
- Mark Manfredi
- Erfahrung
